Posted on 1/6/21
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines . . .
Posted on 1/6/21
Clearside Biomedical Prices of $12 Million Registered Direct Offering
ALPHARETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision . . .
Posted on 1/6/21
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
DUBLIN, Ireland and TREVOSE, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and . . .
Posted on 1/6/21
Radius Health Acquires Orphan Disease Program
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced a definitive agreement to acquire the global development and commercialization rights to Benuvia . . .
Posted on 1/6/21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
WALTHAM, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases . . .
Posted on 1/6/21
VCU Thinks Small for COVID-19 Innovations
The novel coronavirus that causes COVID-19 has upended life across the globe, but it also has spurred innovation and invention.At Virginia Commonwealth University, two researchers have . . .
Posted on 1/6/21
Alachua’s Life Sciences Ecosystem Raises Over $1.0 Billion in 2020
ALACHUA, Fla.--(BUSINESS WIRE)--UF Innovate | Sid Martin Biotech announces the City of Alachua’s life sciences industry has raised more than $1 billion in 2020. The life . . .
Posted on 1/6/21
Is Emergent BioSolutions Stock a Buy?
If you had invested $10,000 in shares of Emergent BioSolutions (NYSE:EBS) at the beginning of last year, that investment would be worth $16,608 as of Dec. . . .
Posted on 1/6/21
Could Johnson & Johnson Be a Millionaire-Maker Stock?
Investors looking for low volatility and steady, reliable returns have been attracted to Johnson & Johnson (NYSE:JNJ) for decades. The company is a Dividend King, having . . .
Posted on 1/6/21
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
On Monday evening, Dr. Stephen M. Hahn, director of the Food and Drug Administration, and Dr. Peter Marks, the director of the FDA's Center for Biologics . . .
Posted on 1/6/21
Pfizer Launches First Major Rebranding in Over 70 Years
Pfizer (NYSE:PFE) has swallowed its little blue pill.No, we don't mean Viagra. On Tuesday, the company formally discarded its long-standing logo, replacing it with a new . . .
Posted on 1/6/21
AmerisourceBergen Primed For A Bounce
SummaryAmerisourceBergen is a pharmaceutical distribution company that has seen solid earnings and revenue growth.The company does have a deal with the CDC to handle the distribution . . .
Posted on 1/6/21
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
On Monday evening, Dr. Stephen M. Hahn, director of the Food and Drug Administration, and Dr. Peter Marks, the director of the FDA's Center for Biologics . . .
Posted on 1/5/21
Scott Outlines City Vaccination Plan, Says He May Reconsider Restrictions
Mayor Brandon Scott said Tuesday he may update citywide restrictions on dining and non-mask wearing activities at the end of this week after his team reviews . . .
Posted on 1/5/21
Maryland Reports 54 More Coronavirus Fatalities as Death Total Nears 6,000
Maryland is approaching 6,000 coronavirus deaths, with state officials on Tuesday reporting 54 more COVID-19 fatalities.As of Tuesday morning, Maryland has confirmed a total of 5,913 . . .
Posted on 1/5/21
Year in Review: Holy Cross Health Participates in COVID-19 and Lung Cancer Clinical Trials and Programs
In a strong commitment to research and development, Holy Cross Health has been participating in COVID-19 and lung cancer related clinical trials and programs throughout 2020. . . .
Posted on 1/5/21
Provident Healthcare Partners Advises Companion Hospice In Its Acquisition By Bristol Hospice
Companion Hospice, a leading hospice and palliative care provider in the Western United States, has had its California operations acquired by Bristol Hospice, a portfolio company . . .
Posted on 1/5/21
Blue Earth Diagnostics Acquires Worldwide Rights to Therapeutic Applications of Scintomics rhPSMA
OXFORD, England & BURLINGTON, Mass.--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that . . .
Posted on 1/5/21
ProPhase Labs Offers $5.5 Million of Common Stock and Warrants
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has . . .
Posted on 1/5/21
Rhythm Pharmaceuticals Sale of Priority Review Voucher for $100M
Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment
Posted on 1/5/21
Riverside Tappahannock Hospital Becomes Part of VCU Health System
Richmond-based VCU Health System announced Monday it has finalized its purchase of the 67-bed Riverside Tappahannock Hospital (RTH) and related medical services from Riverside Health System.Financial . . .
Posted on 1/5/21
Aro Biotherapeutics Closes $88 Million Series A
Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced the closing of an $88 million Series A financing. Northpond Ventures
Posted on 1/5/21
IconOVir Bio Raises $77 Million in Series A Financing
IconOVir Bio, Inc., a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer,
Posted on 1/5/21
The Worst Mistake Novavax Investors Can Make Right Now
Novavax (NASDAQ:NVAX) was in the perfect position to develop a COVID-19 vaccine, having previously succeeded against two similar coronaviruses (SARS and MERS) in the lab. The . . .
Posted on 1/5/21
Quest Diagnostics: A COVID-19 Beneficiary
Summary Quest Diagnostics has effectively captured 24% of a $28Bn market, while earning the loyalty of 11Mn customers digitally by providing low cost, high quality services . . .
